What's Moving Markets Today? -- WSJ
Dow Jones2026/10/22 16:08By Vicky Ge Huang
The Nasdaq composite led major indexes lower Thursday as investors shed some riskier assets such as tech stocks in favor of bonds, driving Treasury yields lower.
-- Oil rises: Oil prices moved higher after fresh strikes on Saudi Arabia and U.S.-Israeli plans for renewed attacks on Iran. Brent crude futures, the global benchmark, are on track to settle at their highest level since May.
-- AI selloff: Major artificial-intelligence stocks are down as investors questioned the sustainability of the debt-fueled AI buildouts. Meta led losses among the so-called hyperscalers, while the PHLX Semiconductor index also dropped.
-- Treasurys fall: Treasury yields fell sharply as investors sought safety. The 10-year yield dropped below 5%.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
October 22, 2026 12:08 ET (16:08 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
$40 billion in bond issuance with a maximum interest rate of 8.3%! SpaceX (SPCX.US) AI gamble also exposes the “funding winter” for AI infrastructure
According to media reports citing sources familiar with the matter, SpaceX is preparing to complete a debt issuance totaling $40 billion, with an interest rate significantly higher than previous borrowing costs, reflecting growing investor concerns over financing for artificial intelligence (AI) infrastructure.

Tom Lee: The market is in a sell-off state, and tech stocks have reached support levels
TS Lombard scenario analysis: An AI bubble burst could trigger a 30% plunge in the S&P 500, wiping out 20 trillion dollars in market value—but don't rush to short!
Dario Perkins from TS Lombard predicted in a scenario analysis released on Thursday that if AI capital expenditure collapses, approximately $20 trillions in U.S. stock market value could evaporate, triggering credit losses of $125 billions to $190 billions.
Gilead Sciences (GILD.US) acquires PepStar’s oral inflammation drug program for $1.275 billion in cash, increasing investment in inflammatory bowel disease pipeline
Gilead Sciences will acquire PepStar’s anti-inflammatory drug program for $1.28 billions.